Latest filing published 08 Jul 2026 for NervGen Pharma Corp., €138k.
Insider track record
Adam Rogers: trading record in brief
This profile gathers the share dealings of Adam Rogers in NervGen Pharma Corp. Over a trading history stretching from 13 July 2022 to 30 June 2026, the count stands at 11 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 8 July 2026, the filings show a share grant worth €138k in NervGen Pharma Corp. Filings reach the SEDI feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Adam Rogers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,713 shares@ CA$3.640.036% mcap2.3% of flowCommon SharesTSXSEDI:4748874
- 37,784 shares@ CA$3.640.022% mcap1.4% of flowCommon SharesTSXSEDI:4748871
- 800,000 shares@ CA$3.6829.8% of flowWarrantsTSXSEDI:4727977
- 800,000 shares@ CA$2.5020.3% of flowCommon SharesTSXSEDI:4727973
- 1,146,108 shares@ CA$3.9946.3% of flowOptionsTSXSEDI:4725769
- 952,381 shares@ CA$2.1014.5% of flowCommon SharesTSXSEDI:4608080
- 857,143 shares@ CA$2.1013.1% of flowCommon SharesTSXSEDI:4608092
- Common SharesTSXSEDI:4608090
- 10,000 shares@ CA$1.740.1% of flowCommon SharesTSXSEDI:4513203
- Common SharesTSXSEDI:3979893
- Common SharesTSXSEDI:3979890
11 of 11 declarations